- Home
- LAES vs RDHL Comparison
LAES vs RDHL Comparison
Compare LAES & RDHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LAES
- RDHL
- Stock Information
- Founded
- LAES 2022
- RDHL 2009
- Country
- LAES Switzerland
- RDHL Israel
- Employees
- LAES N/A
- RDHL N/A
- Industry
- LAES Semiconductors
- RDHL Biotechnology: Pharmaceutical Preparations
- Sector
- LAES Technology
- RDHL Health Care
- Exchange
- LAES Nasdaq
- RDHL Nasdaq
- Market Cap
- LAES 10.7M
- RDHL 11.2M
- IPO Year
- LAES N/A
- RDHL N/A
- Fundamental
- Price
- LAES $0.40
- RDHL $7.05
- Analyst Decision
- LAES Strong Buy
- RDHL
- Analyst Count
- LAES 1
- RDHL 0
- Target Price
- LAES $1.75
- RDHL N/A
- AVG Volume (30 Days)
- LAES 858.6K
- RDHL 14.3K
- Earning Date
- LAES 09-25-2024
- RDHL 11-19-2024
- Dividend Yield
- LAES N/A
- RDHL N/A
- EPS Growth
- LAES N/A
- RDHL N/A
- EPS
- LAES N/A
- RDHL N/A
- Revenue
- LAES $20,135,000.00
- RDHL $3,707,000.00
- Revenue This Year
- LAES N/A
- RDHL $224.90
- Revenue Next Year
- LAES N/A
- RDHL $82.69
- P/E Ratio
- LAES N/A
- RDHL N/A
- Revenue Growth
- LAES N/A
- RDHL N/A
- 52 Week Low
- LAES $0.29
- RDHL $6.80
- 52 Week High
- LAES $3.95
- RDHL $82.00
- Technical
- Relative Strength Index (RSI)
- LAES 55.29
- RDHL 29.71
- Support Level
- LAES $0.31
- RDHL $7.98
- Resistance Level
- LAES $0.46
- RDHL $7.36
- Average True Range (ATR)
- LAES 0.05
- RDHL 0.37
- MACD
- LAES 0.01
- RDHL -0.12
- Stochastic Oscillator
- LAES 72.96
- RDHL 0.00
About LAES SEALSQ Corp
SEALSQ Corp develops certified secure microcontrollers and implements post-quantum cryptography. The company develops solutions including post-quantum microchips and devices that can be used in a variety of applications, from multi-factor authentication, home automation, and IT network infrastructure to automotive, industrial automation, and control systems. Its vaultIC range offers a complete set of ready-to-use secure elements designed to implement embedded security for any kind of device with fast time-to-market and high flexibility. The company's products include VaultIC155, VaultIV18x, VaultIC292, and VaultIC40x. The company generates a majority of its revenue from North America.
About RDHL Redhill Biopharma Ltd.
Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is focused primarily on the advancement of its development pipeline of clinical-stage therapeutic candidates. The company also commercializes in the U.S. GI-related products, Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). The company's current pipeline consists of five therapeutic candidates, which are Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, most of which are in clinical development.